Key Financial Data Of Group

K Pharma,Inc. - Filing #7543382

Concept	As at 2023-08-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2019-12-31	2019-01-01 to 2019-12-31	As at 2018-12-31	2018-01-01 to 2018-12-31
Key financial data of group
Business results of group
Net sales	—	JPY	—	—	JPY	JPY	—	—	JPY	—	JPY
Ordinary profit (loss)	—	-359,233,000 JPY	—	—	-220,892,000 JPY	-269,562,000 JPY	—	—	-255,606,000 JPY	—	-99,958,000 JPY
Net assets	—	—	1,336,263,000 JPY	178,891,000 JPY	—	—	8,009,000 JPY	279,228,000 JPY	—	435,515,000 JPY	—
Total assets	—	—	1,374,566,000 JPY	205,767,000 JPY	—	—	56,983,000 JPY	294,068,000 JPY	—	450,105,000 JPY	—
Net assets per share	—	—	-122.77	-107.03	—	—	-84,539.31	-45,788.18	—	-9,643.65	—
Basic earnings (loss) per share	—	-42.06	—	—	-30.09	-38,751.13	—	—	-37,032.98	—	-16,594.61
Diluted earnings per share	—		—	—			—	—		—
Equity-to-asset ratio	—	—	0.972 xbrli:pure	0.869 xbrli:pure	—	—	0.141 xbrli:pure	0.950 xbrli:pure	—	0.968 xbrli:pure	—
Rate of return on equity	—	xbrli:pure	—	—	xbrli:pure	xbrli:pure	—	—	xbrli:pure	—	xbrli:pure
Price-earnings ratio	—	xbrli:pure	—	—	xbrli:pure	xbrli:pure	—	—	xbrli:pure	—	xbrli:pure
Net cash provided by (used in) operating activities	—	-363,482,000 JPY	—	—	-196,320,000 JPY	JPY	—	—	JPY	—	JPY
Net cash provided by (used in) investing activities	—	-32,737,000 JPY	—	—	-250,000 JPY	JPY	—	—	JPY	—	JPY
Net cash provided by (used in) financing activities	—	1,544,285,000 JPY	—	—	368,201,000 JPY	JPY	—	—	JPY	—	JPY
Cash and cash equivalents	—	—	1,336,847,000 JPY	188,782,000 JPY	—	—	JPY	JPY	—	JPY	—
Number of employees	16 xbrli:pure	—	13 xbrli:pure	11 xbrli:pure	—	—	10 xbrli:pure	9 xbrli:pure	—	7 xbrli:pure	—
Average number of temporary employees	—	—	xbrli:pure	xbrli:pure	—	—	xbrli:pure	xbrli:pure	—	xbrli:pure	—